fenofibrate has been researched along with Diabetic Cardiomyopathies in 4 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fenofibrate treatment had no detectable effect on serum A-FABP level (P > 0." | 2.77 | Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes. ( Barter, PJ; Brown, C; Jenkins, AJ; Keech, AC; O'Connell, R; Ong, KL; Rye, KA; Sullivan, DR; Xu, A, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W | 2 |
| Lai, Y | 1 |
| Wang, L | 1 |
| Xia, Y | 1 |
| Zhao, X | 1 |
| Yu, M | 1 |
| Li, Y | 1 |
| Zhang, Y | 1 |
| Ye, H | 1 |
| Zhang, J | 1 |
| Cheng, Y | 1 |
| Gu, J | 1 |
| Wang, S | 1 |
| Zhou, S | 1 |
| Wang, Y | 1 |
| Tan, Y | 1 |
| Feng, W | 1 |
| Fu, Y | 1 |
| Mellen, N | 1 |
| Cheng, R | 1 |
| Ma, J | 1 |
| Zhang, C | 1 |
| Li, Z | 1 |
| Cai, L | 1 |
| Williams, KH | 1 |
| Sullivan, DR | 2 |
| Nicholson, GC | 1 |
| George, J | 1 |
| Jenkins, AJ | 2 |
| Januszewski, AS | 1 |
| Gebski, VJ | 1 |
| Manning, P | 1 |
| Tan, YM | 1 |
| Donoghoe, MW | 1 |
| Ehnholm, C | 1 |
| Young, S | 1 |
| O'Brien, R | 1 |
| Buizen, L | 1 |
| Twigg, SM | 1 |
| Keech, AC | 2 |
| Ong, KL | 1 |
| Rye, KA | 1 |
| O'Connell, R | 1 |
| Brown, C | 1 |
| Xu, A | 1 |
| Barter, PJ | 1 |
2 trials available for fenofibrate and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Topics: Aged; Alanine Transaminase; Australia; Biomarkers; Cardiovascular Diseases; Diabetes Mellitus, Type | 2016 |
Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Double-Blind Method; Female; Fenofibrate | 2012 |
2 other studies available for fenofibrate and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Astragalus polysaccharides repress myocardial lipotoxicity in a PPARalpha-dependent manner in vitro and in vivo in mice.
Topics: Animals; Astragalus propinquus; Cardiotonic Agents; Cell Line; Diabetic Cardiomyopathies; Dietary Su | 2015 |
Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Topics: Animals; Autophagy; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Ty | 2016 |